Differences in patients with Impulse Control Disorder based on antiparkinsonian drug treatment in a Mexican Institute.
Objective: To describe the differences in multiple factors based on Parkinson's treatment in patients with impulse control disorder Background: In intermediate-advanced phases of PE, psychiatric…A multimodal approach for diagnosis of early Multiple System Atrophy (MSA)
Objective: To describe the use of neuroimaging and fluid biomarkers to improve the diagnostic accuracy of early MSA. Background: The diagnosis of early MSA is…Identification of atlastin genetic modifiers in a Hereditary Spastic Paraplegia model in Drosophila
Objective: To identify genetic modifiers of decreased locomotion and neuromuscular junction defects associated with atlastin knockdown in motor neurons. Background: Hereditary spastic paraplegias (HSPs) are…Billiards-related tremor: a form of task-specific tremor
Objective: To report a patient with billiards-related tremor, a form of task-specific tremor. Background: Task-specific tremor is a tremor that occurs when performing specific tasks…POLR3A-Related Disorders and Response to Deep Brain Stimulation
Objective: To expand on the phenotypic spectrum of POLR3A c.1909+22G>A splice variant and report two patients’ tremor response to deep brain stimulation. Background: Polymerase III…Characterization of gait variability of early Parkinson’s disease and multiple system atrophy
Objective: to determine the potential differences in gait characteristics between PD-GBA carriers and non-carriers (idiopathic Parkinson’s disease (iPD)), both mutually and in relation to MSA-P.…Needs and priorities of people with Parkinson’s and care partners regarding neuropsychiatric symptoms
Objective: To examine the experiences of people with Parkinson’s disease (PD) and care partners (CPs) regarding cognitive, mood, behavioral, and sleep issues. Background: Neuropsychiatric symptoms…Assessment of variation in α-synuclein seed amplification assay results in the PPMI cohort: Association with hyposmia
Objective: To understand molecular heterogeneity among Parkinson’s disease (PD) patients, and controls based on α-synuclein seed amplification assay (SAA) results. Background: α-synuclein seed amplification assay…Efficacy and safety of safinamide in PD patients over 70 years vs. under 70 years old;
Objective: To search for any differences between efficacy and safety of safinamide in PD patients over 70 years vs. under 70 years old. Background: Safinamide…Diabetic striatopathy presenting without hyperkinetic movements
Objective: To demonstrate a case of Diabetic striatopathy presenting without hyperkinetic movements Background: Diabetic striatopathy is an uncommon neurological complication associated with poorly controlled Diabetes Mellitus…
- « Previous Page
- 1
- …
- 328
- 329
- 330
- 331
- 332
- …
- 1554
- Next Page »